Genomics Investment Syndicate III ApS — Credit Rating and Financial Key Figures

CVR number: 25589327
Gl. Skolevej 5, 7800 Skive

Income statement (kDKK)

2020
2021
2022
2023
2024
Fiscal period length1212121212
Net sales
Gross profit-6.13-5.66-7.38-8.70-5.94
EBIT-6.13-5.66-7.38-8.70-5.94
Other financial expenses-21.81-22.41-23.74-23.58-24.27
Reduction non-current investment assets-71.61- 614.26
Pre-tax profit-99.55-28.06-31.12-32.28- 644.47
Net earnings-99.55-28.06-31.12-32.28- 644.47

Assets (kDKK)

2020
2021
2022
2023
2024
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Short term receivables total
Other current investments1 095.891 095.891 095.891 095.89481.63
Cash and bank deposits12.075.312.77
Cash and cash equivalents1 107.961 101.201 098.661 095.89481.63
Balance sheet total (assets)1 107.961 101.201 098.661 095.89481.63

Equity and liabilities (kDKK)

2020
2021
2022
2023
2024
Share capital240.00240.00240.00240.00240.00
Retained earnings222.31122.7694.7063.5831.30
Profit of the financial year-99.55-28.06-31.12-32.28- 644.47
Shareholders equity total362.76334.70303.58271.30- 373.17
Non-current liabilities total
Current loans from credit institutions0.50
Current trade creditors9.288.669.254.004.00
Current owed to participating5.135.1310.5321.5328.23
Other non-interest bearing current liabilities730.79752.72775.30798.56822.58
Current liabilities total745.20766.50795.08824.59854.81
Balance sheet total (liabilities)1 107.961 101.201 098.661 095.89481.63
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.